Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies
Passaro, Antonio, Brahmer, Julie, Antonia, Scott, Mok, Tony, Peters, Solange
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
Hellmann, Matthew D, Paz-Ares, Luis, Bernabe Caro, Reyes, Zurawski, Bogdan, Kim, Sang-We, Carcereny Costa, Enric, Park, Keunchil, Alexandru, Aurelia, Lupinacci, Lorena, de la Mora Jimenez, Emmanuel, Sakai, Hiroshi, Albert, Istvan, Vergnenegre, Alain, Peters, Solange, Syrigos, Konstantinos, Barlesi, Fabrice, Reck, Martin, Borghaei, Hossein, Brahmer, Julie R, O’Byrne, Kenneth J, Geese, William J, Bhagavatheeswaran, Prabhu, Rabindran, Sridhar K, Kasinathan, Ravi S, Nathan, Faith E, Ramalingam, Suresh S
Published in The New England journal of medicine (21.11.2019)
Published in The New England journal of medicine (21.11.2019)
Get full text
Journal Article
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study
Hellmann, Matthew D, Dr, Rizvi, Naiyer A, Prof, Goldman, Jonathan W, MD, Gettinger, Scott N, MD, Borghaei, Hossein, DO, Brahmer, Julie R, MD, Ready, Neal E, Prof, Gerber, David E, MD, Chow, Laura Q, MD, Juergens, Rosalyn A, MD, Shepherd, Frances A, Prof, Laurie, Scott A, MD, Geese, William J, PhD, Agrawal, Shruti, PhD, Young, Tina C, MS, Li, Xuemei, MD, Antonia, Scott J, Prof
Published in The lancet oncology (01.01.2017)
Published in The lancet oncology (01.01.2017)
Get full text
Journal Article
Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer
Drake, Charles G., Lipson, Evan J., Brahmer, Julie R.
Published in Nature reviews. Clinical oncology (01.01.2014)
Published in Nature reviews. Clinical oncology (01.01.2014)
Get full text
Journal Article
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
Reck, Martin, Rodríguez-Abreu, Delvys, Robinson, Andrew G, Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O'Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Vandormael, Kristel, Riccio, Antonio, Yang, Jing, Pietanza, M Catherine, Brahmer, Julie R
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Reck, Martin, Rodríguez-Abreu, Delvys, Robinson, Andrew G, Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O’Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Leiby, Melanie A, Lubiniecki, Gregory M, Shentu, Yue, Rangwala, Reshma, Brahmer, Julie R
Published in The New England journal of medicine (10.11.2016)
Published in The New England journal of medicine (10.11.2016)
Get full text
Journal Article
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50
Reck, Martin, Rodríguez-Abreu, Delvys, Robinson, Andrew G, Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O'Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Leal, Ticiana A, Riess, Jonathan W, Jensen, Erin, Zhao, Bin, Pietanza, M Catherine, Brahmer, Julie R
Published in Journal of clinical oncology (20.07.2021)
Published in Journal of clinical oncology (20.07.2021)
Get full text
Journal Article
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
Forde, Patrick M., Spicer, Jonathan, Lu, Shun, Provencio, Mariano, Mitsudomi, Tetsuya, Awad, Mark M., Felip, Enriqueta, Broderick, Stephen R., Brahmer, Julie R., Swanson, Scott J., Kerr, Keith, Wang, Changli, Ciuleanu, Tudor-Eliade, Saylors, Gene B., Tanaka, Fumihiro, Ito, Hiroyuki, Chen, Ke-Neng, Liberman, Moishe, Vokes, Everett E., Taube, Janis M., Dorange, Cecile, Cai, Junliang, Fiore, Joseph, Jarkowski, Anthony, Balli, David, Sausen, Mark, Pandya, Dimple, Calvet, Christophe Y., Girard, Nicolas
Published in The New England journal of medicine (26.05.2022)
Published in The New England journal of medicine (26.05.2022)
Get full text
Journal Article
Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer
Robichaux, Jacqulyne P., Elamin, Yasir Y., Tan, Zhi, Carter, Brett W., Zhang, Shuxing, Liu, Shengwu, Li, Shuai, Chen, Ting, Poteete, Alissa, Estrada-Bernal, Adriana, Le, Anh T., Truini, Anna, Nilsson, Monique B., Sun, Huiying, Roarty, Emily, Goldberg, Sarah B., Brahmer, Julie R., Altan, Mehmet, Lu, Charles, Papadimitrakopoulou, Vassiliki, Politi, Katerina, Doebele, Robert C., Wong, Kwok-Kin, Heymach, John V.
Published in Nature medicine (01.05.2018)
Published in Nature medicine (01.05.2018)
Get full text
Journal Article
Nivolumab: targeting PD-1 to bolster antitumor immunity
Brahmer, Julie R, Hammers, Hans, Lipson, Evan J
Published in Future oncology (London, England) (01.05.2015)
Published in Future oncology (London, England) (01.05.2015)
Get full text
Journal Article
Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: Results From the CA209-003 Study
Gettinger, Scott, Horn, Leora, Jackman, David, Spigel, David, Antonia, Scott, Hellmann, Matthew, Powderly, John, Heist, Rebecca, Sequist, Lecia V, Smith, David C, Leming, Philip, Geese, William J, Yoon, Dennis, Li, Ang, Brahmer, Julie
Published in Journal of clinical oncology (10.06.2018)
Published in Journal of clinical oncology (10.06.2018)
Get full text
Journal Article
Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy
Taube, Janis M, Klein, Alison, Brahmer, Julie R, Xu, Haiying, Pan, Xiaoyu, Kim, Jung H, Chen, Lieping, Pardoll, Drew M, Topalian, Suzanne L, Anders, Robert A
Published in Clinical cancer research (01.10.2014)
Published in Clinical cancer research (01.10.2014)
Get full text
Journal Article
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Masters, Gregory A, Temin, Sarah, Azzoli, Christopher G, Giaccone, Giuseppe, Baker, Jr, Sherman, Brahmer, Julie R, Ellis, Peter M, Gajra, Ajeet, Rackear, Nancy, Schiller, Joan H, Smith, Thomas J, Strawn, John R, Trent, David, Johnson, David H
Published in Journal of clinical oncology (20.10.2015)
Published in Journal of clinical oncology (20.10.2015)
Get full text
Journal Article
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab
Cappelli, Laura C, Gutierrez, Anna Kristina, Baer, Alan N, Albayda, Jemima, Manno, Rebecca L, Haque, Uzma, Lipson, Evan J, Bleich, Karen B, Shah, Ami A, Naidoo, Jarushka, Brahmer, Julie R, Le, Dung, Bingham, Clifton O
Published in Annals of the rheumatic diseases (01.01.2017)
Published in Annals of the rheumatic diseases (01.01.2017)
Get full text
Journal Article
Immune checkpoint modulation for non-small cell lung cancer
Soria, Jean-Charles, Marabelle, Aurélien, Brahmer, Julie R, Gettinger, Scott
Published in Clinical cancer research (15.05.2015)
Published in Clinical cancer research (15.05.2015)
Get full text
Journal Article
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation
Braaten, Tawnie J, Brahmer, Julie R, Forde, Patrick M, Le, Dung, Lipson, Evan J, Naidoo, Jarushka, Schollenberger, Megan, Zheng, Lei, Bingham III, Clifton O, Shah, Ami A, Cappelli, Laura C
Published in Annals of the rheumatic diseases (01.03.2020)
Published in Annals of the rheumatic diseases (01.03.2020)
Get full text
Journal Article